Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up
Title:
Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up
Author:
Castillo, Jorge J. Meid, Kirsten Flynn, Catherine A. Chen, Jiaji Demos, Maria G. Guerrera, Maria L. Kofides, Amanda Liu, Xia Munshi, Manit Tsakmaklis, Nicholas Patterson, Christopher J. Yang, Guang Hunter, Zachary Treon, Steven P.